Abstract:Jia Huang, 1 Wenjun Li, 2 Yecheng Sun, 1, &ast Zhutang Huang, 1, &ast Rong Cong, 1, &ast Chen Yu, 1, &ast Hongyan Tao 2 1 The Second Clinical Medical School, Lanzhou University, Lanzhou, Gansu, 730000, People's Republic of China; 2 Department of Respiratory, The Second Hospital of Lanzhou University, Lanzhou, Gansu, People's Republic of China &astThese authors contributed equally to this work Correspondence: Hongyan Tao, Department of Respiratory, The Second Hospital of Lanzhou University, Lanzhou, Gansu, People's Republic of China, Email Preserved Ratio Impaired Spirometry (PRISm) manifests notable epidemiological disparities across the globe, with its prevalence and influential factors showcasing pronounced diversities among various geographical territories and demographics. The prevalence of PRISm fluctuates considerably among regions such as Latin America, the United States, and Asian nations, potentially correlating with a myriad of determinants, including socioeconomic status, environmental factors, and lifestyle modalities. Concurrently, the link between PRISm and health risks and other disorders, especially its distinction and interrelation with chronic obstructive pulmonary disease (COPD), has become a pivotal subject of scientific enquiry. Radiographic anomalies, such as perturbations in the pulmonary parenchyma and structural alterations, are posited as salient characteristics of PRISm. Furthermore, PRISm unveils intricate associations with multiple comorbidities, inclusive of hypertension and type 2 diabetes, thereby amplifying the intricacy in comprehending and managing this condition. In this review, we aim to holistically elucidate the epidemiological peculiarities of PRISm, its potential aetiological contributors, its nexus with COPD, and its association with radiographic aberrations and other comorbidities. An integrative understanding of these dimensions will provide pivotal insights for the formulation of more precise and personalised preventative and therapeutic strategies. Keywords: PRISm, pulmonary function, epidemiology, comorbid associations Chronic obstructive pulmonary disease (COPD), which is particularly prevalent among older adults, is a significant contributor to global mortality. A recent proposal suggests that impaired lung growth can lead to COPD, even in the absence of a rapid decline in lung function, and preserved ratio impaired spirometry (PRISm) has been proposed as a concept of low lung growth or early COPD. 1,2 PRISm is a condition characterised by a decline in the one-second ratio with normal pulmonary function. PRISm represents a prevalent yet under-researched state of diminished lung functionality, defined by a forced expiratory volume in one second (FEV1) that is less than 80% of the predicted value, whilst maintaining a FEV1/forced vital capacity (FVC) ratio ≥0.7. 3 This pathological state, although common, has been sparsely researched. Previous investigations have linked it to respiratory symptoms. 4,5 Recently, PRISm has been identified as a subtype that is more susceptible to developing COPD or experiencing acute exacerbations. Observational studies have reported that 32.6% of individuals with PRISm progressed to COPD within 4–5 years. 6,7 However, it remains unknown how PRISm influences the development of COPD. In recent years, an increasing number of studies have been conducted on PRISm, especially in areas such as epidemiology, disease progression, and subtyping. Several studies have indicated associations between PRISm and diminished lung function, airway diseases, and emphysema. 8,9 These findings hold significant implications for understanding the heterogeneity of COPD and the natural history of PRISm. PRISm has also been correlated with various disorders, including obesity, diabetes, and hypertension. 5,10,11 The focal point of current research pivots on discerning individual characteristics of PRISm, and subtyping patients with PRISm, all of which will be important to elucidate its pathophysiological mechanism, optimise diagnosis, and deliver personalised treatment. This review comprehensively encapsulates research pertaining to PRISm, spanning its epidemiology, aetiological factors, relationships with comorbidities, radiographic presentations, disease progression, and prognosis. The objective of this review is to equip clinicians and researchers with a holistic and up-to-date understanding of PRISm to foster improved diagnosis and therapeutic approaches. Globally, the global prevalence of PRISm, estimated at between 7%–13%, remains a focal point of interest. 6,11–15 Nevertheless, this figure does not wholly represent -Abstract Truncated-

Preserved Ratio Impaired Spirometry and COPD Accelerate Frailty Progression: Evidence from a Prospective Cohort Study

Preserved Ratio Impaired Spirometry and COPD Accelerate Frailty Progression

Different Risks of Mortality and Longitudinal Transition Trajectories in New Potential Subtypes of the Preserved Ratio Impaired Spirometry: Evidence From the English Longitudinal Study of Aging

Prevalence, risk factors, and clinical implications of preserved ratio impaired spirometry: a UK Biobank cohort analysis

Association of Frailty with Clinical Outcomes in Chronic Obstructive Pulmonary Disease: A Retrospective Longitudinal Cohort Study

The prevalence, clinical characteristics, and influencing factors of COPD progressed from PRISm: a cohort analysis in primary healthcare organizations in China

Association Between Preserved Ratio Impaired Spirometry and Clinical Outcomes in US Adults

Association of preserved ratio impaired spirometry with mortality and airflow obstruction in the silicotics: a longitudinal cohort study

Abstract 11583: Association Between Baseline and Trajectories of Preserved Ratio Impaired Spirometry (prism) and Mortality in Chinese Adults: Results from the Prospective Urban Rural Epidemiology (PURE) Study

Clinical study on the relationship between the preserved ratio impaired spirometry and chronic obstructive pulmonary disease

Acute Exacerbation and Longitudinal Lung Function Change of Preserved Ratio Impaired Spirometry

Does pulmonary rehabilitation decrease frailty in COPD?

Risk factors, morbidity and mortality in association with Preserved Ratio Impaired Spirometry (PRISm) and Restrictive Spirometric Pattern (RSP)

The Association between Preserved Ratio Impaired Spirometry and Depression: Results from a Prospective Population-Based Study

Patients with PRIS(m) have a high mortality in the longitudinal analysis over a period of 12 years - Results of the BACOP study

Preserved Ratio Impaired Spirometry (PRISm): A Global Epidemiological Overview, Radiographic Characteristics, Comorbid Associations, and Differentiation from Chronic Obstructive Pulmonary Disease

Frailty and Mortality Risk in COPD: A Cohort Study Comparing the Fried Frailty Phenotype and Short Physical Performance Battery

The Impact of Frailty Status on Pulmonary Function and Mortality in Older Patients with Chronic Obstructive Pulmonary Disease

Frailty Assessment in a Stable COPD Cohort: Is There a COPD-Frail Phenotype?

Prevalence of and factors associated with cognitive frailty in elderly patients with chronic obstructive pulmonary disease: A cross-sectional study

The association between preserved ratio impaired spirometry and adverse outcomes of depression and anxiety: evidence from the UK Biobank